Infections and infestations (mainly nasopharyngitis): 46.8% vs
VASCULAR GROWTH & BLOOD VESSEL STIMULATION The peptide BPC-157 may play a role in promoting vascular health and repairing blood vessels through: Enhanced Nitric Oxide (NO) Production It has been shown to activate endothelial nitric oxide synthase (eNOS), improving vascular function and integrity
The peptide displayed a very good safety and tolerability profile indistinguishable from placebo, with no treatment-related serious adverse events or study withdrawals
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
Chapter 2
Custom Protocol Design Our medical team designs a personalized TB-500 protocol including dosage, injection frequency, cycle length, and whether to combine with BPC-157 or other complementary peptides
